Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa, a science writer, holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

March 29, 2021March 29, 2021

CHMP Favors Kaftrio to Treat CF Patients in EU Starting at Age 12

News

A European Medicines Agency (EMA) committee favors extending the label for Kaftrio (ivacaftor/tezacaftor/elexacaftor), in combination with Kalydeco (ivacaftor), to treat cystic fibrosis (CF) patients 12 and older who have at least one copy of ... Read more

March 18, 2021March 18, 2021

Bronchitol, Inhaled Powder for CF Mucus Clearance, Arrives in US

cystic fibrosis, News

Bronchitol (mannitol), an inhaled mucus-clearing treatment for cystic fibrosis (CF), is now commercially available in the U.S., according to Chiesi USA, which is marketing the therapy in the country. “We are ... Read more

January 22, 2021January 22, 2021

Dosing Begins in Extension Study of Yeast-derived Treatment for EPI

cystic fibrosis, News

The first two patients have been dosed in the Phase 2b OPTION 2 extension study evaluating MS1819 in treating exocrine pancreatic insufficiency (EPI) in people with cystic fibrosis (CF), its ... Read more

January 12, 2021January 12, 2021

Phase 1/2 Trial to Test Phage Therapy for Chronic P. aeruginosa Infections

cystic fibrosis, News

A Phase 1/2 clinical trial, called CYPHY, to evaluate the phage therapy YPT-01 in treating chronic Pseudomonas aeruginosa infections in people with cystic fibrosis (CF) has been initiated at Yale ... Read more

January 8, 2021January 8, 2021

Study Examines Effects of Socioeconomics on Health of Youngsters

cystic fibrosis, News

Children with cystic fibrosis (CF) who live in more socioeconomically disadvantaged areas of the U.S. tend to have worse lung function and health outcomes than their counterparts in more affluent ... Read more

January 5, 2021January 5, 2021

Health Canada Giving Priority Review to Trikafta

cystic fibrosis, News

Health Canada is reviewing an application that seeks the approval of Trikafta, a triple combination reported to treat 90% of all with cystic fibrosis (CF), or those with least one F508del mutation. ... Read more

December 16, 2020December 16, 2020

Potential Antibiotic Appears to Effectively Treat M. abscessus Infections

cystic fibrosis, News

A newly developed antibiotic, called T405, appears to effectively kill Mycobacteroides abscessus, a difficult-to-treat bacteria that can cause serious infections in people with lung conditions like cystic fibrosis (CF). The ... Read more

December 10, 2020December 10, 2020

CF Children With COVID-19 Usually Do Not Develop Serious Disease, Study Finds

cystic fibrosis, News

Children with cystic fibrosis (CF) who become infected with SARS-CoV-2 — the virus that causes COVID-19 — usually have a mild disease course, a new study reports. The findings also indicate ... Read more

December 7, 2020December 7, 2020

Study Identifies Risk Factors of Malnutrition in Children With CF

News

Children with cystic fibrosis (CF) who are older, thinner, or have worse lung function may be at increased risk of malnutrition, a study indicates. These findings highlight the importance of ... Read more

December 3, 2020December 3, 2020

BiomX Testing Potential Therapy for CF Lung Infections

cystic fibrosis, News

BiomX has unveiled a platform designed for more rapid and efficient development of phage therapy, which the company is using to test potential treatments, including one for Pseudomonas aeruginosa infections in ... Read more

Join our email list!